NHS England

Showing 15 posts of 55 posts found.

Pharmacists in England given wider prescribing powers to relieve GP pressure

May 9, 2023
Medical Communications GP, NHS England, pharmacists

NHS England had announced that pharmacists in England will be given wider prescribing powers to relieve pressure put on GPs. …

NICE recommends new triple therapy for multiple myeloma patients

March 19, 2021
Medical Communications NHS England, NICE, oncology

A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a …


Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic

June 8, 2020
Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic

Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …


NHS England to supply HIV prevention drug PrEP with £16m government investment

March 16, 2020
Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma

NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …


Austerity policies blamed as English life expectancy stalls for first time in a century

February 25, 2020
Manufacturing and Production England, NHS England, UCL, austerity, life expectancy

A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …


NICE gives initial ‘no’ to NHS England for kidney cancer drug

February 18, 2020
Manufacturing and Production NHS England, NICE, clinical trials, inlyta, keytruda

The National Institute for Health and Care Excellence (NICE) has not recommended Keytruda (pembrolizumab) and Inlyta (axitinib) for the treatment …

Prostate Cancer becomes most commonly diagnosed cancer in England

January 28, 2020
Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer

Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …

HIV infections fall by 73% in bi and gay British men

January 16, 2020
Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland

Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …


NHS to pioneer Novartis injection that reduces cholesterol

January 14, 2020
Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack

The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …

NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza

May 15, 2019
Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy

NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …


NHS England threatened legal action against Oxford University hospitals trust

April 4, 2019
Medical Communications, Research and Development Hopsitals, NHS, NHS England, OUH, cancer screening, patients

NHS England threatened to sue Oxford University hospitals (OUH) NHS trust after they objected to the former’s controversial decision to …

NHS chief warns of rise of anti-vaccine ‘fake news’ online

March 4, 2019
Sales and Marketing NHS, NHS England, Simon Stevens, anti vaxxer, fake news, vaccines

The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’. …

Data reveals November’s performance was worst on record for NHS

December 14, 2018
Medical Communications NHS, NHS England, UK, funding, investment, wait times

November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …


NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …


UK High Court rejects ABPI’s challenge to new NICE cost curbs

October 5, 2017
Sales and Marketing ABPI, NHS, NHS England, NICE, legal, pharma, pharmaceutical

The ABPI has been knocked back by the UK High Court in its legal challenge to NICE over new drug …

Latest content